STARPHARMA HOLDINGS LIMITED - Charts / Financials

Market Cap $43.82M Add to my watchlist

Starpharma Holdings Limited is an Australia-based biopharmaceutical company. The... Starpharma Holdings Limited is an Australia-based biopharmaceutical company. The principal activities of the Company consist of research, development and commercialization of dendrimer products for pharmaceutical, life-science and other applications. It is focused on developing and commercializing novel therapeutic products that address global healthcare needs. The Company is also involved in the development of nano-scale materials, including the development of VivaGel for the management and prevention of bacterial vaginosis, and as an antiviral condom coating, and VIRALEZE, an antiviral nasal spray. The Company is also applying its proprietary dendrimers to drug delivery to create improved pharmaceuticals and has developed the valuable DEP delivery platform. VIRALEZE is a broad-spectrum nasal spray intended to provide a moisturizing and protective barrier in the nose that traps and blocks cold/respiratory viruses. It also offers VivaGel BV and VivaGel Condom products.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

REFRESH

Last update - 15.58pm 15/11/2024 (20 minute delay)

Day
Open	10.5¢		Day High	11.5¢		Day Low	10.0¢
Daily Volume	1006785

Bids				Sellers
Number	Price	Volume		Number	Price	Volume
1	10.5¢	83046		1	11.0¢	30000

Directors & Senior Management

Ms. Cheryl Maley	Chief Executive Officer, Managing Director, Director
Mr. Justin Cahill	Chief Financial Officer, Joint Company Secretary
Dr. Jeremy R. Paull	Vice President - Development and Regulatory Affairs
Dr. A Tony Eglezos	Vice President - Business Development
Ms. Tracy Weimar	Interim Joint Company Secretary
Mr. Robert Bain Thomas	Independent Non-Executive Chairman of the Board
Dr. Russell Basser	Independent Non-Executive Director
Ms. Lynda Cheng	Independent Non-Executive Director
Dr. Jeff R. Davies	Independent Non-Executive Director
Mr. David John Mcintyre	Independent Non-Executive Director

Data source: Refinitiv

(20min delay)
Last 10.5¢		Change 0.000(0.00%)		Mkt cap ! $43.82M

Open	High	Low	Value	Volume
10.5¢	11.5¢	10.0¢	$110.6K	1.006M

Buyers (Bids)

No.	Vol.	Price($)
1	83046	10.5¢

Sellers (Offers)

Price($)	Vol.	No.
11.0¢	30000	1

View Market Depth

No.	Vol.	Price($)
1	6000	0.955
4	25073	0.950
1	3925	0.945
3	8847	0.940
1	10000	0.935

Price($)	Vol.	No.
0.960	4540	2
0.965	15000	1
0.970	13906	2
0.975	10000	1
0.980	19012	1

Last trade - 16.10pm 15/11/2024 (20 minute delay)


Last 10.5¢		Change 0.000 ( 5.00 %)
Open	High	Low	Volume
10.3¢	11.5¢	10.3¢	347942
Last updated 15.58pm 15/11/2024 ?

SPL (ASX) Chart